Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESMO MAP 2022 | Towards molecular cancer prevention: findings from investigations into air pollution induced NSCLC

Emilia Lim, PhD, UCL, London, UK, discusses encouraging findings on preventative measures of air pollution induced non-small cell lung cancer. Through a series of investigations, several genes relating to inflammation were found to be upregulated in both humans and mice exposed to air pollution, some of which may be targetable in cancer prevention measures. Currently, the inflammatory cytokine interleukin-1 beta (IL-1β) is under investigation as a target for air pollution induced lung cancer prevention. This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.